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Abstract
Introduction: Erythema annulare centrifugum is a rare cutaneous disease characterized by erythematous and
violaceous annular plaques that usually involved the thighs and the legs. The eruption may be associated with an
underlying disease and its accompanying characteristic symptoms. For these reasons, a full physical examination
should be conducted to exclude underlying disorders. Annually recurring erythema annulare centrifugum is a rare
and peculiar variant of erythema annulare centrifugum with the same clinical and histopathological characteristics.
The lesions of annually recurring erythema annulare centrifugum tend to regress spontaneously after a variable
period of days to months with yearly recurrence for many years.
Case presentation: We present the case of a 46-year-old caucasian woman affected by annually recurring
erythema annulare centrifugum, which is a peculiar form of superficial erythema annulare centrifugum. The lesions
have the same clinical and histopathological characteristics of the classical superficial form of erythema annulare
centrifugum and tend to regress spontaneously after a variable period of days to months. In our case, no
precipitating factors were identified and no underlying diseases were found. Every year for the last 12 years the
lesions started to appear in the summer months and regressed spontaneously in autumn.
Conclusions: Cases of annually recurring erythema annulare centrifugum are rarely reported in the literature
and generally no causative agent can be detected. The main feature of annually recurring erythema annulare
centrifugum is the constant annual and seasonal recurrence of the lesions for many years.
Keywords: Erythema annulare centrifugum, Type IV hypersensitivity reaction, Idiopathic disease, Seasonal recurrence,
Spontaneous regression
Introduction
Erythema annulare centrifugum (EAC) is a rare cutane-
ous disease characterized by an asymptomatic or pruritic
eruption of variable duration that usually involves the
thighs and the legs. The eruption may be associated with
an underlying disease and its accompanying charac-
teristic symptoms. For these reasons, a full physical
examination should be conducted to exclude underlying
disorders. Annually recurring erythema annulare centri-
fugum (AR EAC) is a peculiar form of superficial EAC.
Christine first described this variant of EAC in 1930 but
until now only few isolated reports have been published
[1]. The lesions, which have the same clinical and histo-
pathological characteristics of the classical superficial
form of EAC, tend to regress spontaneously after a
variable period of days to months with yearly recurrence
for many years. We report the rare case of a patient af-
fected by AR EAC.
Case presentation
A 46-year-old caucasian woman was referred to our de-
partment for evaluation of a relapsing self-healing annu-
lar eruption involving her extremities that had recurred
yearly for the last 12 years. A physical examination re-
vealed multiple erythematous and violaceous annular
plaques involving both legs and arms (Fig. 1). The
eruption began as small erythematous papules that coa-
lesced into annular plaques with central clearing and
centrifugal spread. Our patient had reported that the
lesions were intensely itchy. Some lesions presented a
peripheral scaling border. Her face, hands, foot and
trunk were spared. Our patient reported that the lesions
began to appear every year in the summer months and
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regressed spontaneously in autumn. No mucosal lesions
were present and the rest of the physical examination
disclosed no abnormalities. Her medical history was
unremarkable and our patient did not use drugs. No
precipitating factors were identified. We performed a
complete routine laboratory investigation including im-
munologic tests (immunoglobulins, rheumatoid factor,
antinuclear factor and organ-specific antibodies) and all
values were within the normal range. Borrelia burgdorferi
antibodies and viral serological tests gave negative results.
A potassium hydroxide microscopic slide was prepared,
which yielded a negative result for a fungal infection. Her
chest radiograph and mammogram were normal. Her Pap
test result was negative. A skin biopsy was performed and
the histologic examination revealed a moderately intense
superficial perivascular dermal lymphohistiocytic infiltrate
with rare eosinophils and focal epidermal spongiosis
(Fig. 2). Direct skin immunofluorescence test results were
negative. The clinical and histopathological features, with
a supportive history of recurrent lesions, led to the diag-
nosis of AR EAC. The lesions regressed spontaneously 4
months after onset.
Discussion
EAC is a rare cutaneous disease characterized by annu-
lar erythematous lesions. Generally, it can appear as a
multiple polycyclic lesions simulating urticaria papules
that enlarge centrifugally with central clearing. EAC was
first described by Darier in 1916, and classified in 1978
by Ackerman into a superficial and a deep type [2, 3].
The superficial type is characterized by perivascular lym-
phohistiocytic infiltrate of variable intensity in the papil-
lary and middermis with occasional eosinophils. Edema
of the papillary dermis is usually present. The epidermal
Fig. 1 Multiple erythematous and violaceous annular plaques involving both legs (a) and arms (b, c). Some lesions presented a peripheral
scaling border
Fig. 2 Histopathological findings of the skin biopsy showed a
moderately intense superficial perivascular dermal lymphohistiocytic
infiltrate with rare eosinophils, edema of papillary dermis, hyperkeratosis
and focal epidermal spongiosis. Hematoxylin and eosin stain, original
magnification: ×10 (a), ×20 (b), ×40 (c)
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changes of parakeratosis and spongiosis may be present.
Clinically, these lesions have nonindurated borders, are
scaly and pruritic. Instead, the deep type is characterized
by perivascular lymphohistiocytic infiltrate of variable
intensity in the superficial (papillary and middermis),
but in addition the inflammatory infiltrate involves the
deep dermis (reticular dermis). No epidermal changes
are generally observed. Clinically, these lesions have in-
durated borders, are nonscaly and nonpruritic. The eti-
ology and pathogenesis are unknown [4]. It is believed
that EAC represents a cutaneous manifestation of a type
IV hypersensitivity reaction to different causes and
underlying systemic diseases, including: food allergy,
arthropod bites, drug reactions (finasteride, chloroquine,
hydroxychloroquine, hydrochlorothiazide, piroxicam, eti-
zolam, cimetidine, penicillin, salicylates, spironolactone,
gold sodium thiomalate, amitriptyline, ustekinumab,
rituximab), infections disease (bacterial, viral, parasitic,
fungal, mycobacterial), endocrine and immunological
disorders (menstrual cycle, Graves disease, Hashimoto
thyroiditis, Sjögren syndrome, autoimmune progesterone
dermatitis), hematological and other neoplastic disorders
(Hodgkin lymphoma, non-Hodgkin lymphoma, acute
leukemia, histiocytosis, multiple myeloma, nasopharyngeal
carcinoma, prostatic adenocarcinoma, breast carcinoma,
ovarian carcinoma) [5–10]. Treatment and eradication of
the underlying disease often resolves EAC. The prognosis
for EAC is excellent, except when associated with an
underlying malignancy and other systemic disease. It is
important to highlight that EAC can appear many years
before, concomitantly or after the onset of a malignancy.
For all these reasons, a diagnosis of EAC should be
followed by a full physical examination and diagnostic
workup in order to exclude an underlying disorder. How-
ever, sometimes no causative agent can be identified and
in these cases EAC is considered idiopathic. Our case
represents the peculiar variant of AR EAC, which is only
exceptionally reported in the literature [1, 4, 11]. This
variant has the same clinical and histopathological features
of the classical superficial form of EAC and is usually ob-
served in women (2:1). The average age of onset is 49
years; however, ages can range from 16 to 83 years [11].
The lesions tend to involve the legs and arms and sporad-
ically the trunk, while the face, hands and foot are always
spared. The lesions, which appear constantly during the
spring or summer months, tend to regress spontaneously
after a variable period of days to months with yearly recur-
rence for many years. Normally, no causative agent can be
detected and for this reason AR EAC is usually considered
an idiopathic disease. Moreover, associated symptoms are
generally not present. Nevertheless, a full physical examin-
ation and diagnostic workup is very important in order to
exclude an underlying disorder. Until now no effective
treatment has been described. Photosensitivity is a
tempting theory but the presence of lesions in nonexposed
skin areas and the absence of facial and trunk involvement
seem to rule out the role of sun exposure. It could be
hypothesized that environmental factors (temperature,
seasonal plants or fungus) explain the periodic course of
the disease, but further studies would be necessary.
Conclusions
AR EAC is a peculiar form of superficial EAC and until
now only few isolated reports have been published. AR
EAC is generally considered an idiopathic disease be-
cause no causative agent can be detected. The main fea-
ture of AR EAC is the constant annual and seasonal
recurrence of the lesions for many years.
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